Hippocampal SPARC regulates depression-related behavior

por Campolongo, M., Benedetti, L., Podhajcer, O.L., Pitossi, F., Depino, A.M.

Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritic model

por Chernajovsky, Y., Adams, G., Triantaphyllopoulos, K., Ledda, M.F., Podhajcer, O.L.

Effect of estradiol and tamoxifen on the anchorage-independent growth of the subpopulations derived from MCF-7 breast carcinoma cells: Cytogenetic analysis of the stem cell subpopu...

por Podhajcer, O.L., Resnicoff, M., Bover, L., Medrano, E.E., Slavutsky, I., Larripa, I., Mordoh, J.

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

por Fernanda Ledda, M., Adris, S., Bravo, A.I., Kairiyama, C., Bover, L., Chernajovsky, Y., Mordoh, J., Podhajcer, O.L.

Biologic, Immunocytochemical, and Cytogenetic Characterization of Two New Human Melanoma Cell Lines: IIB‐MEL‐LES and IIB‐MEL‐IAN

por KAIRIYAMA, C., SLAVUTSKY, I., LARRIPA, I., MORVILLO, V., BRAVO, A.I., BOVER, L., PODHAJCER, O.L., MORDOH, J.

Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.

por Ledda, M.F., Adris, S., Bravo, A.I., Bover, L., Carbone, C., Paleolog, E., Mordoh, J., Chernajovsky, Y., Podhajcer, O.L.

Contraste ontológico: una herramienta para el análisis de experimentos de proteómica/genómica funcional

por Fresno, C., Llera, A. S., Girotti, M. R., Valacco, M. P., López, J. A., Podhajcer, O. L., Balzarini, M. G., Prada, F., Fernández, E. A.
Publicado 2011

TarSeqQC: Quality control on targeted sequencing experiments in R

por Merino, G.A., Murua, Y.A., Fresno, C., Sendoya, J.M., Golubicki, M., Iseas, S., Coraglio, M., Podhajcer, O.L., Llera, A.S., Fernández, E.A.

Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells

por Sosa, M.S., Girotti, M.R., Salvatierra, E., Prada, F., De Olmo, J.A.L., Gallango, S.J., Albar, J.P., Podhajcer, O.L., Llera, A.S.

Gene therapy for rheumatoid arthritis. Theoretical considerations

por Chernajovsky, Y., Annenkov, A., Herman, C., Triantaphyllopoulos, K., Gould, D., Dreja, H., Moyes, S.P., Croxford, J.L., Mageed, R.A., Podhajcer, O.L., Baker, D.

Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC

por Guttlein, L.N., Benedetti, L.G., Fresno, C., Spallanzani, R.G., Mansilla, S.F., Rotondaro, C., Iraolagoitia, X.L.R., Salvatierra, E., Bravo, A.I., Fernandez, E.A., Gottifredi, V., Zwirner, N.W., Llera, A.S., Podhajcer, O.L.